Definium Therapeutics Inc. Common Shares vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $330.98M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 13.9× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| DFTX | XDTE | |
|---|---|---|
Market Cap | $4.59B | $330.98M |
Volume | 2,103,937 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $48.45 | $44.76 |
52-Week Low | $10.68 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $3.55B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →